Neuberger Berman Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-216,903
Closed -$4.99M 2132
2025
Q2
$4.99M Buy
216,903
+26,651
+14% +$617K ﹤0.01% 965
2025
Q1
$4.27M Buy
+190,252
New +$4.42M ﹤0.01% 965
2022
Q3
Sell
-78,310
Closed -$2.28M 1889
2022
Q2
$2.28M Buy
78,310
+69,475
+786% +$1.77M ﹤0.01% 1079
2022
Q1
$237K Hold
8,835
﹤0.01% 1762
2021
Q4
$228K Buy
+8,835
New +$220K ﹤0.01% 1800
2021
Q3
Sell
-8,400
Closed -$373K 1806
2021
Q2
$373K Buy
+8,400
New +$310K ﹤0.01% 1541

Other funds holding PRVA

Neuberger Berman Group's PRVA Position: Q3 2025 in Review

Neuberger Berman Group sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 216,903 shares — an estimated $4.99M sold.

Neuberger Berman Group first reported a position in PRVA in Q2 2021 and held it in 6 quarters. The position peaked at $4.99M in Q2 2025. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Neuberger Berman Group reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
  • Neuberger Berman Group sold 216,903 Privia Health shares in Q3 2025, an estimated $4.99M.
  • Neuberger Berman Group first reported a position in Privia Health in Q2 2021 and held it in 6 quarters.
  • Neuberger Berman Group's Privia Health position peaked at $4.99M in Q2 2025.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Neuberger Berman Group's 13F filing for Q3 2025, filed 12 Nov 2025.